Carole Ho
Chief Tech/Sci/R&D Officer chez DENALI THERAPEUTICS INC.
Fortune : 7 M $ au 31/03/2024
Profil
Carole Ho, MD, est directrice indépendante de NGM Biopharmaceuticals, Inc. et de Beam Therapeutics, Inc. et directrice médicale et chef du développement de Denali Therapeutics, Inc. Elle est membre du conseil d'administration de NGM Biopharmaceuticals, Inc. et de Beam Therapeutics, Inc. Auparavant, le Dr Ho a occupé le poste de vice-présidente du développement clinique précoce des produits non oncologiques chez Genentech, Inc. et celui de directrice médicale chez Johnson & Johnson. Elle a obtenu son diplôme de premier cycle au Harvard College et un doctorat au Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DENALI THERAPEUTICS INC.
0,25% | 14/02/2024 | 351 824 ( 0,25% ) | 7 M $ | 31/03/2024 |
BEAM THERAPEUTICS, INC.
-.--% | 06/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Carole Ho
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/06/2015 |
| BEAM THERAPEUTICS INC. | Director/Board Member | 15/11/2018 |
Anciens postes connus de Carole Ho
| Sociétés | Poste | Fin |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 05/04/2024 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/06/2015 |
| JOHNSON & JOHNSON | Chief Tech/Sci/R&D Officer | 01/10/2007 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Carole Ho
| Cornell University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| DENALI THERAPEUTICS INC. | Health Technology |
| BEAM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
